{"raw_mentions": "In some embodiments, the compound or pharmaceutically acceptable salt thereof may demonstrate an EC50 value (e.g., in Hela cells) of less than 0.05 \u03bcM.\nIn some embodiments, the compound or pharmaceutically acceptable salt thereof may demonstrate an EC50 value (e.g., in Hela cells) of from 0.05 \u03bcM to less than 0.2 \u03bcM."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "<0.05", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "0.05 to <0.2", "unit": "\u03bcM"}]}
{"raw_mentions": "In some embodiments, the compound or pharmaceutically acceptable salt thereof may demonstrate an EC50 value (e.g., in Hela cells) of from 0.2 \u03bcM to less than 0.5 \u03bcM.\nIn some embodiments, the compound or pharmaceutically acceptable salt thereof may demonstrate an EC50 value (e.g., in Hela cells) of from 0.5 \u03bcM to 1 \u03bcM."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "0.2 to <0.5", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "0.5 to 1", "unit": "\u03bcM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\n(S)-3-((S)-2-(4-methoxy-1H-indole-2- carboxamido)-4-methylpentanamido)- 2-oxo-4-((S)-2-oxopyrrolidin-3- yl)butyl pentadecanoate698.2** \n(S)-3-((S)-2-(2-((2- fluorophenyl)amino)-2- oxoacetamido)-4- methylpentanamido)-2-oxo-4-((S)-2- oxopiperidin-3-yl)butyl 2- cyanobenzoate608.53***EC50: <0.05 \u03bcM \n\n\nNote that the other sentences do not contain all four required components: a specific molecule name, a bioactivity metric, a numeric value, and a unit. The provided text appears to be a patent application, and the relevant information is embedded in the descriptions of the compounds and their properties."}
{"final_json": [{"molecule_name": "(S)-3-((S)-2-(4-methoxy-1H-indole-2-carboxamido)-4-methylpentanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butyl pentadecanoate", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "698.2", "unit": null}, {"molecule_name": "(S)-3-((S)-2-(2-((2-fluorophenyl)amino)-2-oxoacetamido)-4-methylpentanamido)-2-oxo-4-((S)-2-oxopiperidin-3-yl)butyl 2-cyanobenzoate", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "<0.05", "unit": "\u03bcM"}]}
